Billing details

Your order

Product Subtotal
Do faster drug approvals increase safety risks? Evidence from Canada and Europe 2003-2012.  × 1 $10.00
Les coûts potentiels découlant de la substitution thérapeutique des médicaments au Québec.  × 1 $10.00
Comparing access to new medicines by therapeutic class in public and private sector plans in Canada.  × 1 $10.00
Drugs and the public cost of healthcare in Canada.  × 1 $10.00
Subtotal $40.00
HST (13%) $5.20
Total $45.20
  • Pay via PayPal.

Your personal data will be used to process your order, support your experience throughout this website, and for other purposes described in our privacy policy.